Profound Medical (PROF) Short Interest Ratio & Short Volume → This Wall Street stock prediction just went viral (From Chaikin Analytics) (Ad) Free PROF Stock Alerts $8.54 +0.33 (+4.02%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Profound Medical Short Interest DataCurrent Short Volume310,200 sharesPrevious Short Volume313,700 sharesChange Vs. Previous Month-1.12%Dollar Volume Sold Short$2.31 millionShort Interest Ratio / Days to Cover9.3Last Record DateApril 30, 2024Outstanding Shares24,430,000 sharesPercentage of Shares Shorted1.27%Today's Trading Volume41,184 sharesAverage Trading Volume39,276 sharesToday's Volume Vs. Average105% Short Selling Profound Medical ? Sign up to receive the latest short interest report for Profound Medical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPROF Short Interest Over TimePROF Days to Cover Over TimePROF Percentage of Float Shorted Over Time Ad Chaikin AnalyticsThis Wall Street stock prediction just went viralPeople around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history.Watch just the first 5 minutes of his new prediction Profound Medical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024310,200 shares $2.31 million -1.1%N/A9.3 $7.44 4/15/2024313,700 shares $2.48 million -2.9%N/A8 $7.90 3/31/2024323,200 shares $2.76 million +0.8%N/A7.6 $8.53 3/15/2024320,700 shares $2.73 million -2.3%N/A5.1 $8.52 2/29/2024328,100 shares $3.02 million -4.6%1.7%5.3 $9.20 2/15/2024343,900 shares $2.92 million -1.8%1.8%6.2 $8.49 Get the Latest News and Ratings for PROF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024350,100 shares $3.12 million +6.4%1.8%6.7 $8.92 1/15/2024329,100 shares $2.50 million -23.6%1.7%7.5 $7.60 12/31/2023430,600 shares $3.66 million +37.1%N/A10.8 $8.49 12/15/2023314,200 shares $2.99 million +3.2%N/A16.1 $9.52 11/30/2023304,600 shares $3.30 million +4.2%N/A18.8 $10.85 11/15/2023292,400 shares $2.76 million +11.2%N/A18.3 $9.44 10/31/2023262,900 shares $2.18 million +0.2%N/A17.6 $8.31 10/15/2023262,400 shares $2.44 million +5.6%N/A17.7 $9.30 9/30/2023248,400 shares $2.53 million +33.8%N/A15.2 $10.20 9/15/2023185,600 shares $1.48 million +6.8%N/A10.7 $8.00 8/31/2023173,800 shares $1.55 million -13.3%N/A8.2 $8.89 8/15/2023200,400 shares $1.94 million +2.3%N/A7.7 $9.67 7/31/2023195,900 shares $2.24 million -14.5%1.0%6.9 $11.45 7/15/2023229,000 shares $3.02 million -10.8%1.2%7.6 $13.20 6/30/2023256,600 shares $3.34 million -27.1%1.3%8.4 $13.01 6/15/2023351,900 shares $4.79 million -10.3%1.8%11.7 $13.62 5/31/2023392,300 shares $4.73 million -5.1%2.0%15 $12.05 5/15/2023413,500 shares $5.24 million -1.1%2.1%16.3 $12.67 4/30/2023418,200 shares $4.85 million -4.0%2.1%17.4 $11.60 4/15/2023435,700 shares $4.40 million -0.8%2.2%16.9 $10.10 3/31/2023439,100 shares $4.08 million -1.4%2.2%15.6 $9.29 3/15/2023445,100 shares $4.65 million -3.6%2.3%11.2 $10.45 2/28/2023461,900 shares $6.07 million +1.4%2.4%7.5 $13.15 2/15/2023455,500 shares $5.56 million -3.4%2.3%7.1 $12.21 1/31/2023471,700 shares $5.83 million +4.8%2.4%6.9 $12.35 1/15/2023450,100 shares $5.55 million +3.0%2.3%5.9 $12.34 12/30/2022437,000 shares $4.76 million +63.6%2.3%5 $10.89 12/15/2022267,200 shares $2.36 million +0.4%1.4%3 $8.82 11/30/2022266,200 shares $1.27 million -4.3%1.4%3.2 $4.76 11/15/2022278,200 shares $1.43 million -3.1%1.4%3.7 $5.13 10/31/2022287,100 shares $1.19 million -35.0%1.5%4.1 $4.14 10/15/2022441,500 shares $1.58 million +3.6%2.3%7.3 $3.57 9/30/2022426,200 shares $1.72 million +12.0%2.3%8.9 $4.04 9/15/2022380,500 shares $1.98 million +0.2%2.0%10.4 $5.20Amazon's betting big on this unknown AI company (Ad)Amazon's Betting Big on This Unknown AI Company Amazon has just made a stunning $144 million investment in one small AI company.Discover why this company PROF Short Interest - Frequently Asked Questions What is Profound Medical's current short interest? Short interest is the volume of Profound Medical shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 310,200 shares of PROF short. Learn More on Profound Medical's current short interest. What is a good short interest ratio for Profound Medical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PROF shares currently have a short interest ratio of 9.0. Learn More on Profound Medical's short interest ratio. Is Profound Medical's short interest increasing or decreasing? Profound Medical saw a decrease in short interest during the month of April. As of April 30th, there was short interest totaling 310,200 shares, a decrease of 1.1% from the previous total of 313,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Profound Medical's short interest compare to its competitors? Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to Profound Medical: Orchestra BioMed Holdings, Inc. (3.85%), CVRx, Inc. (9.06%), Accuray Incorporated (5.66%), Quipt Home Medical Corp. (1.61%), Alpha Tau Medical Ltd. (0.06%), ClearPoint Neuro, Inc. (4.96%), Delcath Systems, Inc. (3.34%), AVITA Medical, Inc. (6.69%), AngioDynamics, Inc. (5.37%), Utah Medical Products, Inc. (2.56%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Profound Medical stock? Short selling PROF is an investing strategy that aims to generate trading profit from Profound Medical as its price is falling. PROF shares are trading up $0.56 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Profound Medical? A short squeeze for Profound Medical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PROF, which in turn drives the price of the stock up even further. How often is Profound Medical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PROF, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Orchestra BioMed Short Squeeze CVRx Short Squeeze Accuray Short Squeeze Quipt Home Medical Short Squeeze Alpha Tau Medical Short Squeeze ClearPoint Neuro Short Squeeze Delcath Systems Short Squeeze AVITA Medical Short Squeeze AngioDynamics Short Squeeze Utah Medical Products Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PROF) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap Sniper